Search - tctmd.com

Displaying 461 - 480 of 625

Sort: Relevancy | Date

Presentation TCT 2017

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

TCT 88: Catheter-Based Tricuspid Valve Replacement Via Right Atrium: An Animal Experimental Study

Presenter: Joachim Schofer, Ralph Stephan von Bardeleben, Peng Cao, MD

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

Presenter: Reginald I. Low, Michael J. Rinaldi, Mani Arsalan, MD

October 31, 2017

Presentation TCT 2017

TCT 87: Transcatheter Pledget-Assisted Suture Tricuspid Annuloplasty (PASTA)

Presenter: Joachim Schofer, Ralph Stephan von Bardeleben, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 33: Effect of Percutaneous Paravalvular Leak Closure on Hemolysis

Presenter: Reginald I. Low, Michael J. Rinaldi, Sidakpal Panaich, MD

October 31, 2017

Presentation TCT 2017

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman

October 31, 2017

Presentation TCT 2017

Switzerland Presents: Cases Demonstrating TAVR Limitations

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Peter Wenaweser

October 31, 2017

Presentation TCT 2017

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble

October 31, 2017

Presentation TCT 2017

Canada Presents: Mitral, Tricuspid, and Aortic Valve Transcatheter Cases

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Anita Asgar

October 31, 2017

Presentation TCT 2017

Vietnam Presents: Challenging Cases of Mitral Valvuloplasty

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen

October 31, 2017

Presentation TCT 2017

Case #3 Conclusion: How We Managed This Patient

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Case Comments: How Should We Manage This Patient?

Presenter: Nick Curzen, Rod H. Stables, Roman Tarasov

October 31, 2017

Presentation TCT 2017

Korea Presents: A Case of Valve-in-Valve TAVR

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Bon-Kwon Koo

October 31, 2017

Presentation TCT 2017

Case #3 Introduction: Patient With Previous CABG Undergoes Successful Transfemoral TAVR via a Tortuous Aorta; and a Few Hours Later, He Becomes Hypotensive, Complains of Chest Pain, and Has T-Wave Inversion in V1-V3

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Case Comments: What Does the Literature Tell Us?

Presenter: Nick Curzen, Rod H. Stables, Margaret B. McEntegart

October 31, 2017

Presentation TCT 2017

Case Comments: What Antithrombotic/Antiplatelet Regimen Should We Start?

Presenter: Nick Curzen, Rod H. Stables, Alexey Protopopov

October 31, 2017

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Advertisement

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

TCT 88: Catheter-Based Tricuspid Valve Replacement Via Right Atrium: An Animal Experimental Study

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

TCT 87: Transcatheter Pledget-Assisted Suture Tricuspid Annuloplasty (PASTA)

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 33: Effect of Percutaneous Paravalvular Leak Closure on Hemolysis

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Switzerland Presents: Cases Demonstrating TAVR Limitations

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Canada Presents: Mitral, Tricuspid, and Aortic Valve Transcatheter Cases

Vietnam Presents: Challenging Cases of Mitral Valvuloplasty

Case #3 Conclusion: How We Managed This Patient

Case Comments: How Should We Manage This Patient?

Korea Presents: A Case of Valve-in-Valve TAVR

Case #3 Introduction: Patient With Previous CABG Undergoes Successful Transfemoral TAVR via a Tortuous Aorta; and a Few Hours Later, He Becomes Hypotensive, Complains of Chest Pain, and Has T-Wave Inversion in V1-V3

Case Comments: What Does the Literature Tell Us?

Case Comments: What Antithrombotic/Antiplatelet Regimen Should We Start?

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content